In an unusual sequence of events, Judge Freeman reconsidered and withdrew her previous ruling that plaintiff Fitness Anywhere LLC’s (“TRX”) Patent No. 7,806,814 (“’814 Patent”) was invalid.

TRX accused defendant Woss Enterprises LLC’s (“Woss”) of infringing the ’814 Patent via sales of Woss’s resistant exercise bands.  In August 2016, Judge Freeman granted Woss’s motion for summary judgment that the ’814 Patent was invalid as obvious in light of U.S. Patent No. 7,044,896 (“’896 Patent”) and U.S. Patent No. 7,090,622 (“’622 Patent”).  All three patents have the same named inventor.
Continue Reading

In one of the first post-Berkheimer decisions to invalidate patent claims on the pleadings, Judge Yvonne Gonzalez Rogers invalidated thirty-seven claims across four patents asserted in fourteen cases filed by Cellspin Soft, Inc. because the claims were patent-ineligible.  Her order makes clear that an invention’s benefits must be disclosed in the patent specification, and not just advocated by the party enforcing the patent.  While some initially saw the February 2018 Berkheimer decision from the Federal Circuit as a death knell for Rule 12(b)(6) motions under Section 101, Judge Gonzalez Rogers’ order demonstrates how courts and infringement defendants may use a broad patent specification’s failure to describe the claimed invention’s purported improvements and benefits to invalidate it at the pleadings stage.[1]

Case Background and Asserted Patents.  On October 16, 2017, Plaintiff Cellspin Soft, Inc., filed thirteen lawsuits against popular consumer electronics manufacturers and distributors, including Canon USA, GoPro, Inc., Fitbit, Inc., and NIKE, Inc.  The complaints allege that digital cameras, smart watches, fitness tracking wearables, and other popular devices infringe various claims in U.S. Patent Nos. 8,734,794, 8,892,752, 9,749,847, and 9,258,698.  On December 1, Cellspin Soft filed a fourteenth case against JK Imaging Ltd., a digital camera manufacturer.
Continue Reading